_id
690dae35ccc777a4e85d0a6c
Ticker
AMHD
Name
HLK Biotech Holding Group Inc
Exchange
PINK
Address
2612 Granby Street, Norfolk, VA, United States, 23517
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.amelotholdings.com
Description
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.
Last Close
0.0002
Volume
2500
Current Price
0.0002
Change
0
Last Updated
2026-01-20T15:18:34.898Z
Image
-
Ipo Date
-
Market Cap
925
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2017-09-30
Revenue
0
Cost Of Revenue
0
Gross Profit
0
Operating Expenses
0
Operating Income
-641
Interest Expense
-
Pretax Income
-641
Net Income
-641
Eps
-0.0001
Dividends Per Share
-
Shares Outstanding
4625159
Income Tax Expense
0
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
103780
Total Assets
112380
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
63075
Equity
49305
Bs_currency_symbol
USD
Depreciation
641
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
USD
PE
-
PB
0.026001419734306867
ROE
-1.3000709867153433
ROA
-0.5703861897134722
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
31
Deep Value Investing Score
3
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2017-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
0
Quarters > 0 > income Statement > operating Income
-641
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-641
Quarters > 0 > income Statement > net Income
-641
Quarters > 0 > income Statement > eps
-0.0001
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6410000
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
103780
Quarters > 0 > balance Sheet > total Assets
112380
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
63075
Quarters > 0 > balance Sheet > equity
49305
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-641
Quarters > 0 > cash Flow > depreciation
641
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0001
Quarters > 0 > ratios > PB
0.026001419734306867
Quarters > 0 > ratios > ROE
-1.3000709867153433
Quarters > 0 > ratios > ROA
-0.5703861897134722
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2017-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
0
Quarters > 1 > income Statement > operating Income
-641
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-641
Quarters > 1 > income Statement > net Income
-641
Quarters > 1 > income Statement > eps
-0.0001
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6410000
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
104421
Quarters > 1 > balance Sheet > total Assets
113021
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
64407
Quarters > 1 > balance Sheet > equity
48614
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-641
Quarters > 1 > cash Flow > depreciation
641
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.0001
Quarters > 1 > ratios > PB
0.02637100423746246
Quarters > 1 > ratios > ROE
-1.318550211873123
Quarters > 1 > ratios > ROA
-0.5671512373806638
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2017-03-31
Quarters > 2 > income Statement > revenue
2319
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
2319
Quarters > 2 > income Statement > operating Expenses
0
Quarters > 2 > income Statement > operating Income
-1032
Quarters > 2 > income Statement > interest Expense
300
Quarters > 2 > income Statement > pretax Income
-1332
Quarters > 2 > income Statement > net Income
-1332
Quarters > 2 > income Statement > eps
-0.0003
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4440000
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-44.5019404915912
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
105062
Quarters > 2 > balance Sheet > total Assets
113662
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
9682
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
63075
Quarters > 2 > balance Sheet > equity
50587
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1332
Quarters > 2 > cash Flow > depreciation
641
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-691
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-1713
Quarters > 2 > cash Flow > net Change In Cash
-2404
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0003
Quarters > 2 > ratios > PB
0.017553917014252674
Quarters > 2 > ratios > ROE
-2.633087552137901
Quarters > 2 > ratios > ROA
-1.1718956203480495
Quarters > 2 > ratios > FCF
-691
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.29797326433807675
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2016-12-31
Quarters > 3 > income Statement > revenue
1917
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
1917
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
-98
Quarters > 3 > income Statement > interest Expense
469
Quarters > 3 > income Statement > pretax Income
-567
Quarters > 3 > income Statement > net Income
-567
Quarters > 3 > income Statement > eps
-0.0001
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5670000
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-5.112154407929056
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2404
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2404
Quarters > 3 > balance Sheet > property Plant Equipment
105703
Quarters > 3 > balance Sheet > total Assets
116707
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
16540
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
64788
Quarters > 3 > balance Sheet > equity
51919
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-567
Quarters > 3 > cash Flow > depreciation
641
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
74
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
5231
Quarters > 3 > cash Flow > net Change In Cash
5305
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.0001
Quarters > 3 > ratios > PB
0.021841714979102065
Quarters > 3 > ratios > ROE
-1.092085748955103
Quarters > 3 > ratios > ROA
-0.4858320409229952
Quarters > 3 > ratios > FCF
74
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.038601982263954095
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2016-12-31
Annuals > 0 > income Statement > revenue
8329
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
8329
Annuals > 0 > income Statement > operating Expenses
0
Annuals > 0 > income Statement > operating Income
-912
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-3769
Annuals > 0 > income Statement > net Income
-3769
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-10.949693840797215
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2404
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2404
Annuals > 0 > balance Sheet > property Plant Equipment
105703
Annuals > 0 > balance Sheet > total Assets
116707
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
16540
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
64788
Annuals > 0 > balance Sheet > equity
51919
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3769
Annuals > 0 > cash Flow > depreciation
2564
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-1205
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3604
Annuals > 0 > cash Flow > net Change In Cash
2399
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-7.2593848109555275
Annuals > 0 > ratios > ROA
-3.2294549598567355
Annuals > 0 > ratios > FCF
-1205
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.1446752311201825
Annuals > 0 > health Score
25
Annuals > 1 > quarter
2015-12-31
Annuals > 1 > income Statement > revenue
12224
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
12224
Annuals > 1 > income Statement > operating Expenses
0
Annuals > 1 > income Statement > operating Income
-3118
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
1
Annuals > 1 > income Statement > net Income
1
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-25.507198952879577
Annuals > 1 > income Statement > total Other Income Expense Net
8441
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
5
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5
Annuals > 1 > balance Sheet > property Plant Equipment
108267
Annuals > 1 > balance Sheet > total Assets
116872
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
25786
Annuals > 1 > balance Sheet > long Term Debt
16541
Annuals > 1 > balance Sheet > total Liabilities
61184
Annuals > 1 > balance Sheet > equity
55688
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1
Annuals > 1 > cash Flow > depreciation
2564
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
2565
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-2644
Annuals > 1 > cash Flow > net Change In Cash
-79
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
0.001795719005889958
Annuals > 1 > ratios > ROA
0.000855636936135259
Annuals > 1 > ratios > FCF
2565
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.20983311518324607
Annuals > 1 > health Score
47
Annuals > 2 > quarter
2014-12-31
Annuals > 2 > income Statement > revenue
18095
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
18095
Annuals > 2 > income Statement > operating Expenses
0
Annuals > 2 > income Statement > operating Income
-11363
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-19092
Annuals > 2 > income Statement > net Income
-19092
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-62.796352583586625
Annuals > 2 > income Statement > total Other Income Expense Net
8441
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
84
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
84
Annuals > 2 > balance Sheet > property Plant Equipment
110831
Annuals > 2 > balance Sheet > total Assets
121356
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
23342
Annuals > 2 > balance Sheet > long Term Debt
42327
Annuals > 2 > balance Sheet > total Liabilities
65669
Annuals > 2 > balance Sheet > equity
55687
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-19092
Annuals > 2 > cash Flow > depreciation
2564
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-16528
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
13847
Annuals > 2 > cash Flow > net Change In Cash
-2681
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-34.284482913426835
Annuals > 2 > ratios > ROA
-15.73222584791852
Annuals > 2 > ratios > FCF
-16528
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.9134014921248964
Annuals > 2 > health Score
25
Annuals > 3 > quarter
1998-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
180000
Annuals > 3 > income Statement > gross Profit
-180000
Annuals > 3 > income Statement > operating Expenses
707391
Annuals > 3 > income Statement > operating Income
-707391
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-1038339
Annuals > 3 > income Statement > net Income
-1038339
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-330948
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
63377
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
168346
Annuals > 3 > balance Sheet > property Plant Equipment
85402
Annuals > 3 > balance Sheet > total Assets
852425
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
100000
Annuals > 3 > balance Sheet > long Term Debt
400000
Annuals > 3 > balance Sheet > total Liabilities
1475894
Annuals > 3 > balance Sheet > equity
-623469
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1038339
Annuals > 3 > cash Flow > depreciation
6226
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-441751
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-311742
Annuals > 3 > cash Flow > cash From Financing
816000
Annuals > 3 > cash Flow > net Change In Cash
62507
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
166.5422017774741
Annuals > 3 > ratios > ROA
-121.81001261108015
Annuals > 3 > ratios > FCF
-441751
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
-0.0001
Valuation > metrics > PB
0.026001419734306867
Valuation > final Score
70
Valuation > verdict
97.4% Undervalued
Profitability > metrics > ROE
-1.3000709867153433
Profitability > final Score
30
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2792820200790995
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
30
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
50
Prev Risks > 1
16
Prev Risks > 2
29
Prev Liquidities > 0
50
Prev Liquidities > 1
10
Prev Liquidities > 2
17
Updated At
2026-01-20T21:22:54.074Z
Earnings History > 0 > period
2017-12-31
Earnings History > 0 > report Date
2017-12-31
Earnings History > 0 > date
2017-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0039
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2017-09-30
Earnings History > 1 > report Date
2017-09-30
Earnings History > 1 > date
2017-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0001
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2017-06-30
Earnings History > 2 > report Date
2017-06-30
Earnings History > 2 > date
2017-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0001
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2017-03-31
Earnings History > 3 > report Date
2017-03-31
Earnings History > 3 > date
2017-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0003
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2016-12-31
Earnings History > 4 > report Date
2016-12-31
Earnings History > 4 > date
2016-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0001
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2016-09-30
Earnings History > 5 > report Date
2016-09-30
Earnings History > 5 > date
2016-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0002
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2016-06-30
Earnings History > 6 > report Date
2016-06-30
Earnings History > 6 > date
2016-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0002
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2016-03-31
Earnings History > 7 > report Date
2016-03-31
Earnings History > 7 > date
2016-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0003
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALarry Ellison’s Company Helps Hawaii Find Housing For Key Mental Health Hire - civilbeat.org
3/8/2023
Larry Ellison’s Company Helps Hawaii Find Housing For Key Mental Health Hire civilbeat.org
Read more →(Last Updated 2017-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of HLK Biotech Holding Group Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2017-12-31
EPS Actual
-0.0039
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2017-09-30)
(Last Updated 2017-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2017-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2017-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.